| 영문 | influenza virus | 한글 | 인플루엔자바이러스 |
|---|---|---|---|
| 설명 | 인플루엔자의 병원체. 상기도 점막에 침입하여 호흡기 질환을 일으킨다. 보체 결합 항원의 차이에 따라 A-B-C 세형태로 나뉘며, 유행할 때마다 혈구 응집 항원이 변이하여 광범위한 유행을 나타낸다. 껍질이 있는 80~150nm의 공모양, 나선 대칭 RNA 바이러스이다. 두 종류의 스파이크, 뉴라미니다아제(neuraminidase, NA), 당단백질과 헤마글루티닌(hemagglution, HA) 당단백질을 만든다. A형의 NA에는 N1-N2의 두 종류, HA에는 HAO-HA1-HA2-HA3의 네 종류가 있다. A형은 말-돼지-새에 감염하며 새로운 아형은 동물 바이러스와의 조환형이며, 그 밖에 동일 아형내 점변이가 있다. B, C형은 사람 이외에는 감염되지 않는다. 닭의 적혈구를 응집하는 성질이 있다. 바이러스 진단에는 환자의 인두 세척액에서 분리한다든가, 또는 환자의 혈청항체에 의한 특이적 적혈구 응집저지검사, 뉴라미니다아제 활성저지검사 또는 중화검사 등으로 검출한다. |
||
| 영문 | influenza | 한글 | 인플루엔자 |
|---|---|---|---|
| 설명 | 기도를 침범하는 바이러스 감염증. 지역유행성, 유행성 또는 범발성으로 발생한다. 범발성의 경우는 여러 대륙을 동시에 또는 연속적으로 침범한다. 코점막, 인두, 결막의 염증, 두통, 때때로 전신의 심한 근육통이 특징이다. 심장근과 중추신경계가 침해되는 일은 적다. 괴사기관지염과 간질폐렴이 중증 인플루엔자의 주된 증상이다. 환자는 폐렴알균(Streptococcus pneumoniae), 인플루엔자균(Hemophilus influenzae), 황색포도알균(Staphylococus aureus)에 의한 속발성 세균성 폐렴에 걸리기 쉽다. 잠복기는 1~3, 질병기간은 통상 3~10일이다. 인플루엔자는 A(많은 아군이 있다), B, C로 이름지어진 여러 가지의 혈청학적으로 다른 바이러스주에 의해 발생한다. |
||
| 영문 | virus | 한글 | 바이러스 |
|---|---|---|---|
| 설명 | 박테리아보다 덜 진화된, 생물과 무생물의 중간단계에 해당하는 것. 혼자서는 생존능력이 없으므로 반드시 다른 세포내에 속해 있어야 한다. 인체에 발생하는 많은 병중, 이 바이러스로 인해 발생하는 경우가 많으며, 이 때 대부분 특이한 치료법은 없는 실정이다. 일부 헤르페스바이러스 계통에는 치료약이 개발되어 있지만, 이것도 일부 질병에서만 치료가 가능하다. 또한, Ebstein-Barr virus, Human papilloma virus 등은 암의 발생과 연관되어 있으며, 동물에서 발생하는 대부분의 암종은 바이러스와 연관되어 있는 경우가 많다. 요즘, 일부 지역에서 큰 유행을 하고 있는 후천성면역결핍증후군(AIDS)도 HIV(Human Immunodeficiency Virus)와 관련이 있다. |
||
| 영문 | simian virus | 한글 | 원숭이바이러스 |
|---|---|---|---|
| 설명 | 원숭이에서 분리된 바이러스. 아데노바이러스, 엔테로바이러스, 헤르페스바이러스 및 레오바이러스 등의 여러 군에 속한다. |
||
| BHK | baby hamster kidney [cells]; type-B Hong Kong [influenza virus] |
|---|---|
| IVV | influenza virus vaccine; intravenous vasopressin |
| HBPV | Haemophilus influenza type B Polysaccharide(PRP) Vaccine; B형 헤모필루스 인플루엔자 피막 다당질 백신... |
| flu | influenza |
| HEV | health and environment; hemagglutinating encephalomyelitis virus; hepatitis E virus; hepato-encephal... |
| AIV | Avian influenza virus |
|---|---|
| IAV | Influenza A virus |
| SIV | Swine influenza virus |
| AI | Avian influenza |
| Hib | H influenza type B |
| influenza virus | <organism, virology> Member of the Orthomyxoviridae that causes influenza in humans. There are three types of influenza virus. Each type of virus has a stable nucleoprotein group antigen common to all strains of the type, but distinct from that of the other type; each also has a mosaic of surface antigens (haemagglutinin and neuraminidase) which characterise the strains and which are subject to variations of two kinds: 1) a rather continual drift that occurs independently within the haemagglutinin and neuraminidase antigens; 2) after a period of years, a sudden shift (notably in type A virus of human origin) to a different haemagglutinin or neuraminidase antigen. The sudden major shifts are the basis of subdivisions of type A virus of human origin. Type A causes the world wide epidemics (pandemics) of influenza and can infect other mammals and birds. Type B only affects humans. Type C causes only a mild infection. Types A and B virus evolve continuously, resulting in changes in the antigenicity of their spike proteins, preventing the development of prolonged immunity to infection. The spike proteins, external haemagglutinin and neuraminidase have been studied as models of membrane glycoproteins. Strain notations indicate type, geographic origin, year of isolation, and, in the case of type A strains, the characterizing subtypes of haemagglutinin and neuraminidase antigens (e.g., A/Hong Kong/1/68 (H3 N2); B/Hong Kong/5/72). (08 Mar 2000) |
|---|---|
| influenza virus vaccines | Influenza virus grown in embryonated eggs and inactivated, usually by the addition of formalin; both whole virus and subunit preparations containing haemagglutinins and neuraminidase are used; because of the marked and progressive antigenic variation of the influenza viruses, the strains included are regularly changed following various outbreaks of influenza in order to include most recently isolated epidemic strains of both type A influenza and type B influenza. (05 Mar 2000) |
| influenza viruses | Virus's of the family Orthomyxoviridae which cause influenza and influenza-like infections of humans and other animals; virus's included are influenza virus types A and B of the genus Influenzavirus, causing, respectively, influenza A and B, and influenza virus type C, which probably belongs to a separate genus and causes influenza C. (05 Mar 2000) |
| avian influenza virus | <virology> A type A influenza virus (genus Influenzavirus) that causes fowl plague. Synonym: fowl plague virus. (05 Mar 2000) |
|---|---|
| haemagglutinin glycoproteins, influenza virus | Membrane glycoproteins from influenza viruses which are involved in haemagglutination, virus attachment, and envelope fusion. Fourteen distinct subtypes of ha glycoproteins and nine of na glycoproteins have been identified from influenza a virus; no subtypes have been identified for influenza b or influenza c viruses. (12 Dec 1998) |
| duck influenza virus | An influenza A virus, a member of the family Orthomyxoviridae, distinct from human influenza A strains on bases of haemagglutination-inhibition. (05 Mar 2000) |
| influenza a virus | The type species of the genus influenzavirus a, b that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is by aerosol (human and most non-aquatic hosts) or waterborne (ducks). (12 Dec 1998) |
| influenza a virus, avian | Strains of influenza a virus causing influenza in birds. Transmission is caused by close contact or is waterborne in aquatic species. (12 Dec 1998) |
| influenza a virus, human | Strains of influenza a virus causing influenza and sometimes pneumonia in humans. Transmission is by aerosol. (12 Dec 1998) |
| influenza a virus, porcine | Strains of influenza a virus causing influenza and pneumonia in domestic pigs. (12 Dec 1998) |
| influenza b virus | Species of the genus influenzavirus a, b that cause influenza and other diseases in humans only. Antigenic variation is less extensive than in type a viruses (influenza a virus) and consequently there is no basis for distinct subtypes or variants. Epidemics are less likely than with type a and there have been no pandemics. (12 Dec 1998) |
| Asian influenza | A worldwide influenza, apparently originating in China in the summer of 1957, which produces a milder disease than that of the pandemic of 1917-1919. (05 Mar 2000) |
| avian influenza | Infection of domestic and wild fowl and other birds with influenza a virus, avian. (12 Dec 1998) |
| vaccine, influenza | See Vaccine, flu. Vaccination, dtap: like dpt, dtap protects from diphtheria, pertussis (whooping cough) and tetanus. Dtap is the same as dtp, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. Dtap is currently recommended only for the shots given at 18 months and 4-6 years of age. Vaccination, dt: dt (diphtheria and tetanus) vaccine does not protect from pertussis and is usually reserved for individuals who have had a significant adverse reaction to a dpt shot or who have a personal or family history of a seizure disorder or brain disease. (12 Dec 1998) |
| Russian influenza | A pandemic of a strain influenza A virus thought to have originated in Russia; occurred in 1978. (05 Mar 2000) |
| Haemophilus influenza | <bacteria> A gram-negative bacteria that is a common cause for epiglottitis, meningitis, conjunctivitis, sepsis and respiratory infections. Haemophilus influenza type b is a gram-negative bacteria that is responsible for a significant percentage of bacterial sepsis (blood-borne infection) cases in infants under 4 months of age (pneumonia, epiglottitis, sepsis, septic arthritis, cellulitis). There is a new vaccination available to protect against this common infant pathogen (HIB vaccine, haemophilus influenza b vaccine). (27 Sep 1997) |
| Haemophilus influenza b vaccine | <virology> A vaccination that is given to infants to protect against infection with haemophilus influenza b, an important cause of neonatal sepsis. Typically administered at 2, 4, 6 and 15 months. Children who are aged 15 months to 5 years, who have not received the vaccine, should be given a single injection of haemophilus b conjugate vaccine. Acronym: HIB (26 Mar 1998) |
| Haemophilus influenza meningitis | <disease> A form of meningitis caused by the bacterium haemophilus influenza. Inflammation of the membranes (meninges) covering the brain and spinal cord can result after infection with this organism. Influenza meningitis occurs most frequently in children under 5 years old. Onset may be sudden or occur more slowly after an upper respiratory infection. Symptoms and features include fever, headache, stiff neck, photophobia and mental status changes. Infants may be irritable and exhibit poor feeding associated with fever. Severe cases may progress to seizures, coma and death. Treatment always includes high-dose systemic antibiotics and corticosteroids may also be used in some select cases. (27 Sep 1997) |
| influenza virus |
any of a group of orthomyxoviruses that cause influenza, including at least three serotypes: Influenzavirus A, Influenzavirus B, and Influenzavirus C. Antigenic variants are classified on the basis of their surface antigens (hemagglutinin and neuraminidase) as H1N1, H2N2, etc. Serotype A viruses are subject to major antigenic changes (antigenic shifts) as well as minor gradual antigenic changes (antigenic drift) and cause the major pandemics. ...
출처: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|---|
| influenza virus v. |
[USP] a killed virus vaccine, available as whole virion, subvirion, and purified-surface-antigen preparations. The composition of the vaccine is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains; the vaccine is trivalent, containing two influenza A virus strains and one influenza B virus strain. Annual immunization before November is recommended for high-risk individuals (persons over 65 years of age and persons with chronic disease).
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|